- Home
- CHDN vs IBRX Comparison
CHDN vs IBRX Comparison
Compare CHDN & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHDN | IBRX |
|---|---|---|
| Founded | 1928 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 8.4B |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CHDN | IBRX |
|---|---|---|
| Price | $83.32 | $8.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $135.60 | $12.57 |
| AVG Volume (30 Days) | 1.0M | ★ 28.4M |
| Earning Date | 04-22-2026 | 02-23-2026 |
| Dividend Yield | ★ 0.50% | N/A |
| EPS Growth | N/A | ★ 38.71 |
| EPS | ★ 5.49 | N/A |
| Revenue | ★ $1,809,800,000.00 | $113,288,000.00 |
| Revenue This Year | $5.61 | $88.57 |
| Revenue Next Year | $3.56 | $146.98 |
| P/E Ratio | $16.01 | ★ N/A |
| Revenue Growth | 13.31 | ★ 668.31 |
| 52 Week Low | $81.66 | $1.83 |
| 52 Week High | $118.46 | $12.43 |
Technical Indicators
Market Signals| Indicator | CHDN | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.64 | 53.63 |
| Support Level | $81.66 | $2.27 |
| Resistance Level | $105.84 | $12.43 |
| Average True Range (ATR) | 3.24 | 0.67 |
| MACD | 0.21 | -0.17 |
| Stochastic Oscillator | 17.36 | 28.11 |
Price Performance
Historical ComparisonAbout CHDN Churchill Downs Incorporated
Churchill Downs Inc is a gaming entertainment, online wagering, and racing company. It operates through three business segments: Live and Historical Racing, Wagering Services, and Gaming. The Live and Historical Racing segment includes live and historical pari-mutuel racing. The Wagering Services segment includes the revenue and expenses from pari-mutuel wagers through TwinSpires, companies retail and online sports betting business and Gaming segment includes revenue and expenses for the casino properties and associated racetracks that support the casino license. The Gaming segment generates revenue and expenses from slot machines, video lottery terminals, video poker, HRMs, ancillary food and beverage services, hotel services, commission on pari-mutuel wagering, and racing events.
About IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.